KEY FINDINGS
The Asia Pacific Alzheimer's disease therapeutics and diagnostics market is estimated to register a CAGR of 5.67% during the forecast period, 2021-2028. The increasing number of age-induced dementia cases is set to propel market growth in the Asia Pacific.
MARKET INSIGHTS
China, South Korea, Japan, India, Vietnam, Indonesia, Australia & New Zealand, Thailand, and the rest of Asia Pacific are evaluated for the Asia Pacific Alzheimer's disease therapeutics and diagnostics market growth analysis. As per the United Nations Population Fund 2017 report, in India, the number of dementia cases is projected to reach 1.3 million in 2020 and 1.7 million by 2030. Also, the rising burden of Alzheimer's disease has led to the growing demand for new healthcare technological advancements in the treatment and early diagnosis of dementia. Moreover, the geriatric population is set to increase, which is set to drive market growth. The country is participating in massive collaborative research work for Alzheimer's. At the same time, there is a lack of industry-sponsored research for enhancing the current medications, and improving diagnostic modalities for Alzheimer's and R&D for developing new interventions. India is expected to project a moderate growth during the forecast period, despite considerable efforts at the national level for Alzheimer's.
In Australia, the number of dementia cases is expected to reach 1,076,129 by 2058, according to Dementia Australia. Further, dementia is one of the most significant healthcare challenges in New Zealand, as per Alzheimer.org data. The Australia & New Zealand Alzheimer's disease therapeutics and diagnostics market is consolidated, and the current policies and framework are estimated to fuel the market growth further.
COMPETITIVE INSIGHTS
Some of the distinguished players in the market include, Pfizer Inc, Novartis AG, GE Healthcare, Johnson & Johnson, Eli Lilly & Company, Sun Pharmaceuticals Industries Ltd, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Asia Pacific Alzheimer's Disease Therapeutics And Diagnostics Market Forecast 2021-2028
Table Of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Parent Market Analysis
3.2. Key Drivers
3.2.1. Growing Geriatric Population
3.2.2. Rise In The Pervasiveness Of Alzheimer's Disease
3.2.3. Emerging Novel Diagnostic Technologies
3.3. Key Restraints
3.3.1. Failure Of The Late-Stage Drugs
3.3.2. Stringent Government Regulations
3.3.3. Lack Of The Availability Of Surrogate Markers
4. Key Analytics
4.1. Porter's Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer's Power
4.1.4. Supplier's Power
4.1.5. Competitive Rivalry
4.2. Impact Of Covid-19 On Alzheimer's Disease Therapeutics And Diagnostics Market
4.3. Key Buying Criteria
4.4. Etymology Of Alzheimer's Disease Therapeutics And Diagnostics Market
4.5. Supply Chain Analysis
4.6. Phases And Sternness Of Alzheimer's Disease
4.7. Opportunity Matrix
4.8. Vendor Landscape
4.9. Key Investment Insights
5. Market By Therapeutics And Diagnostics
5.1. Therapeutics
5.1.1. Therapeutics By Drugs
5.1.1.1. Marketed Drugs
5.1.1.2. Pipeline Drugs
5.1.2. Therapeutics By Disease Stage
5.1.2.1. Late Stage: Severe Ad
5.1.2.2. Early/Middle Stage: Mild To Moderate Ad
5.1.2.3. Prodromal Stage
5.1.3. Therapeutics By Generic And Branded
5.1.3.1. Branded
5.1.3.2. Generic
5.2. Diagnostics
5.2.1. Lumbar Puncture Test
5.2.2. Positron Emission Tomography
5.2.3. Electroencephalography
5.2.4. Magnetic Resonance Imaging
5.2.5. Computed Tomography
5.2.6. Other Diagnostics
6. Geographical Analysis
6.1. Asia Pacific
6.1.1. China
6.1.2. India
6.1.3. Japan
6.1.4. Australia & New Zealand
6.1.5. South Korea
6.1.6. Thailand
6.1.7. Indonesia
6.1.8. Vietnam
6.1.9. Rest Of Asia Pacific
7. Competitive Landscape
7.1. Key Strategic Developments
7.1.1. Merger & Acquisitions
7.1.2. Product Launch & Developments
7.1.3. Partnership, Contract/Agreement & Collaboration
7.1.4. Business Expansion/ Approval/ Announcement
7.2. Company Profiles
7.2.1. Allergan Plc (Acquired By Abbvie)
7.2.2. Amarantus Bioscience Holdings Inc
7.2.3. Baxter International Inc
7.2.4. Biogen Inc
7.2.5. Cognoptix Inc
7.2.6. Eisai Co Ltd
7.2.7. Eli Lilly & Company
7.2.8. F. Hoffmann-La Roche
7.2.9. Ge Healthcare
7.2.10. Johnson & Johnson
7.2.11. Lupin Limited
7.2.12. Merck & Co Inc
7.2.13. Novartis Ag
7.2.14. Pfizer Inc
7.2.15. Sun Pharmaceuticals Industries Ltd
List Of Tables
Table 1: Market Snapshot - Alzheimer's Disease Therapeutics And Diagnostics
Table 2: Asia Pacific Alzheimer's Disease Therapeutics And Diagnostics Market, By Therapeutics And Diagnostics, Historical Years, 2016-2020 (In $ Million)
Table 3: Asia Pacific Alzheimer's Disease Therapeutics And Diagnostics Market, By Therapeutics And Diagnostics, Forecast Years, 2021-2028 (In $ Million)
Table 4: Asia Pacific Therapeutics Market, By Drugs, Historical Years, 2016-2020 (In $ Million)
Table 5: Asia Pacific Therapeutics Market, By Drugs, Forecast Years, 2021-2028 (In $ Million)
Table 6: Asia Pacific Therapeutics Market, By Disease Stage, Historical Years, 2016-2020 (In $ Million)
Table 7: Asia Pacific Therapeutics Market, By Disease Stage, Forecast Years, 2021-2028 (In $ Million)
Table 8: Asia Pacific Therapeutics Market, By Generic And Branded, Historical Years, 2016-2020 (In $ Million)
Table 9: Asia Pacific Therapeutics Market, By Generic And Branded, Forecast Years, 2021-2028 (In $ Million)
Table 10: Asia Pacific Diagnostics Market, By Type, Historical Years, 2016-2020 (In $ Million)
Table 11: Asia Pacific Diagnostics Market, By Type, Forecast Years, 2021-2028 (In $ Million)
Table 12: Asia Pacific Alzheimer's Disease Therapeutics And Diagnostics Market, By Country, Historical Years, 2016-2020 (In $ Million)
Table 13: Asia Pacific Alzheimer's Disease Therapeutics And Diagnostics Market, By Country, Forecast Years, 2021-2028 (In $ Million)
List Of Figures
Figure 1: Porter's Five Force Analysis
Figure 2: Supply Chain Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Key Investment Insights
Figure 6: Asia Pacific Alzheimer's Disease Therapeutics And Diagnostics Market, By Therapeutics, 2021-2028 ($ Million)
Figure 7: Asia Pacific Therapeutics Market, By Marketed Drugs, 2021-2028 ($ Million)
Figure 8: Asia Pacific Therapeutics Market, By Pipeline Drugs, 2021-2028 ($ Million)
Figure 9: Asia Pacific Therapeutics Market, By Late Stage: Severe Ad, 2021-2028 ($ Million)
Figure 10: Asia Pacific Therapeutics Market, By Early/Middle Stage: Mild To Moderate Ad, 2021-2028 ($ Million)
Figure 11: Asia Pacific Therapeutics Market, By Prodromal Stage, 2021-2028 ($ Million)
Figure 12: Asia Pacific Therapeutics Market, By Branded, 2021-2028 ($ Million)
Figure 13: Asia Pacific Therapeutics Market, By Generic, 2021-2028 ($ Million)
Figure 14: Asia Pacific Alzheimer's Disease Therapeutics And Diagnostics Market, By Diagnostics, 2021-2028 ($ Million)
Figure 15: Asia Pacific Diagnostics Market, By Lumbar Puncture Test, 2021-2028 ($ Million)
Figure 16: Asia Pacific Diagnostics Market, By Positron Emission Tomography, 2021-2028 ($ Million)
Figure 17: Asia Pacific Diagnostics Market, By Electroencephalography, 2021-2028 ($ Million)
Figure 18: Asia Pacific Diagnostics Market, By Magnetic Resonance Imaging, 2021-2028 ($ Million)
Figure 19: Asia Pacific Diagnostics Market, By Computed Tomography, 2021-2028 ($ Million)
Figure 20: Asia Pacific Diagnostics Market, By Other Diagnostics, 2021-2028 ($ Million)
Figure 21: Asia Pacific Alzheimer's Disease Therapeutics And Diagnostics Market, Country Outlook, 2020 & 2028 (In %)
Figure 22: China Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 23: India Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 24: Japan Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 25: Australia & New Zealand Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 26: South Korea Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 27: Thailand Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 28: Indonesia Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 29: Vietnam Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Figure 30: Rest Of Asia Pacific Alzheimer's Disease Therapeutics And Diagnostics Market, 2021-2028 (In $ Million)
Global Thyroid Gland Disorders Treatment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 80
Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted.
The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......
Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 98
According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......
Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period.
The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......
Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period.
The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......
Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......
Global Enzyme Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 113
According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period.
The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......
Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 84
According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period.
The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......
Global Hormone Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 128
According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......
Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 107
According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period.
The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
